Searchable abstracts of presentations at key conferences in endocrinology

ea0021p237 | Neuroendocrinology and behaviour | SFEBES2009

Profiling the metabolic clearance and enzymatic degradation of the gut hormone Peptide YY as a tool to design long-acting PYY3–36 analogues in treating obesity

Addison Melisande , Thompson Emily , Minnion James , Murphy Kevin , Ghourab Samar , Hostomska Klara , Ghatei Mohammad , Bloom Stephen

Peptide YY (PYY) is a satiety hormone that communicates nutritional status to the central nervous system. PYY is released postprandially from endocrine L-cells in proportion to calories consumed. It is processed to generate the principle bioactive form PYY3–36, which acts on Y2 receptors in feeding centres within the brainstem and hypothalamus to reduce appetite. Chronic intravenous infusion of PYY3–36 induces weight loss in rodents, and obese humans display low plas...